Home > PE Ratio > NEULAND LABORATORIES

NEULAND LABORATORIES
PE (Price/Earnings) Ratio

The Current P/E Ratio of NEULAND LABORATORIES is 30.90.

Share Price ₹7,654.8Apr 18,2024
Market Cap ₹9,798.1 Cr
Earnings-TTM₹317.1 CrTTM-Consolidated Results
Price/Earnings30.90xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for NEULAND LABORATORIES
Please provide your vote to see the results
NEULAND LABORATORIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals

Definition & Calculation of PE (Price/Earnings) ratio of NEULAND LABORATORIES

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of NEULAND LABORATORIES is calculated as :

Current Market Cap [ ₹9,798.1 Cr] as on Apr 18,2024

(/) Earnings [ ₹317.1 Cr] based on TTM-Consolidated Results

(=) P/E Ratio [ 30.90x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for NEULAND LABORATORIES , the investors are currently willing to pay 30.90 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of NEULAND LABORATORIES !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of NEULAND LABORATORIES over the last five years.

Historical PE (Price/Earnings) ratio chart of NEULAND LABORATORIES


PE Ratio Performance Analysis for NEULAND LABORATORIES

- NEULAND LABORATORIES 's latest p/e ratio is 30.90x.

- NEULAND LABORATORIES 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 28.61x.

- NEULAND LABORATORIES 's operated at median p/e ratio of 22.43x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, NEULAND LABORATORIES 's p/e ratio peaked in Mar2019 at 52.62x.

- NEULAND LABORATORIES 's p/e ratio hit its five-year low in Mar2023 of 14.12x.


How does NEULAND LABORATORIES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
NEULAND LABORATORIES 317.0630.909,798.1
SUN PHARMACEUTICAL INDUSTRIES LTD8,998.6340.45364,015.0
CIPLA LTD3,744.0329.06108,809.0
DR REDDYS LABORATORIES LTD5,209.4019.0899,408.7
ZYDUS LIFESCIENCES LTD2,954.2031.8994,213.7
DIVIS LABORATORIES LTD1,382.9771.3698,684.0
MANKIND PHARMA LTD1,743.3055.0996,037.1
TORRENT PHARMACEUTICALS LTD1,494.0057.7186,219.0
LUPIN LTD1,809.7440.1372,621.1
AUROBINDO PHARMA LTD2,777.8923.5265,326.3
ABBOTT INDIA LTD1,145.5848.3355,366.4

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs NEULAND LABORATORIES 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 19.08x
Max industry PE 71.36x
Median industry PE 40.13x
Average industry PE 40.68x



You may also like the below Video Courses